1,357 results on '"Mannucci P. M."'
Search Results
2. Comorbidities in persons with haemophilia aged 60 years or more compared with age‐matched people from the general population
3. Polypharmacy in older adults with severe haemophilia
4. Ageing successfully with haemophilia: A multidisciplinary programme
5. Timing and severity of inhibitor development in recombinant versus plasma‐derived factor VIII concentrates: a SIPPET analysis
6. Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People
7. Incidence of low‐titre factor VIII inhibitors in patients with haemophilia A: meta‐analysis of observational studies
8. Laboratory monitoring of replacement therapy for major surgery in von Willebrand disease
9. Inappropriate prescription of allopurinol and febuxostat and risk of adverse events in the elderly: results from the REPOSI registry
10. E-learning to improve the drug prescribing in the hospitalized elderly patients: the ELICADHE feasibility pilot study
11. Role of apolipoprotein(a) kringle-IV type 2 copy number variation in venous thromboembolism: OR270
12. Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis: reply
13. The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease
14. Recombinant porcine factor VIII: a new instalment of a long story
15. Thromboembolic incidence with transiently elevated levels of coagulation factors in patients with von Willebrand disease treated with VWF:FVIII concentrate during surgery
16. Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis
17. Management of orthopaedic surgery in rare bleeding disorders
18. Novel investigations on the protective role of the FVIII/VWF complex in inhibitor development
19. Kreuth III: European consensus proposals for treatment of haemophilia with coagulation factor concentrates
20. Making clinical decisions on the basis of RODIN
21. Integrated postural analysis in children with haemophilia
22. Orthopaedic surgery in patients with von Willebrand disease
23. La ricerca farmacoeconomica italiana su riviste internazionali
24. Inhibitor development in previously treated hemophilia A patients: a systematic review, meta-analysis, and meta-regression
25. European Haemophilia Network (EUHANET): PB 3.37–2
26. Clinical efficacy and safety of DDAVP with or without tranexamic acid in inherited VWD: final results of the prospective and international study on 229 patients: PA 2.08–1
27. European monitoring of inhibitor development in haemophilia A and B: OC 22.2
28. Models for institutional and professional accreditation of haemophilia centres in Italy
29. Is haemophilia B less severe than haemophilia A?
30. Evolution of the European guidelines for the clinical development of factor VIII products: little progress towards improved patient management
31. Prophylaxis in severe forms of von Willebrandʼs disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN)
32. State of Care for Hemophilia in Pediatric Patients
33. Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysis
34. Markers of activation of coagulation and fibrinolysis in patients with Cushing’s syndrome
35. Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism
36. Detection of non-inhibitory binding antibodies to von Willebrand factor affecting the clearance of VWF:Ag in von Willebrand disease: PO-MO-255
37. The JAK2 V617F mutation in patients with cerebral venous thrombosis
38. Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A
39. Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies
40. Non-thrombotic-, non-inhibitor-associated adverse reactions to coagulation factor concentrates for treatment of patients with hemophilia and von Willebrandʼs disease: a systematic review of prospective studies
41. Health-related quality of life and psychological well-being in elderly patients with haemophilia
42. The role of natural VWF/FVIII complex concentrates in contemporary haemophilia care: a guideline for the next decade
43. Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients
44. Solicited self-referencing undermines the credibility of researchers and journals
45. Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors
46. Central nervous system bleeding in patients with rare bleeding disorders
47. Factor VIII inhibitors in previously treated hemophilic patients
48. Treatment of haemophilia: building on strength in the third millennium
49. Platelet reactive conformation and multimeric pattern of von Willebrand factor in acquired thrombotic thrombocytopenic purpura during acute disease and remission
50. Deep intronic variations may cause mild hemophilia A
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.